Action for XP (SCIO) is a UK based Registered Charity that exists to create, fund and implement global projects and initiatives to improve quality of life for patients and families affected by the very rare condition of Xeroderma Pigmentosum

Registered Charity No: SC045465

Alström Syndrome UK (ASUK) is a charity who provide information, support and advice for individuals affected, their families, carers and professionals. Alström Syndrome is a very rare genetic condition which can cause progressive blindness, loss of hearing and can lead to; heart and kidney failure, type 2 diabetes, liver dysfunction and associated problems. We endeavour to raise awareness, conduct pioneering research and enable further insights, treatments and monitoring through the AS multi-disciplinary NHS clinics.

Angelman UK is a UK based charity supporting families affected by Angelman Syndrome (AS), a rare neurogenetic disorder causing poor mobility, seizures, little or no speech and poor sleep. Their main aims are to support families coming to terms with diagnosis and dealing with the challenges of life with AS; raising awareness of AS among health professionals and the general public and assisting individuals and organisations carrying out research into AS.

Ataxia and Me, has a focus on `patients helping patients` to bring benefits to all affected by the rare neurological condition of Ataxia, which affects balance, speech and coordination. Although, the main focus is Ataxia - they also incorporate associated rare disease and movement disorders. The broad scope of this platform gives a more holistic view of the information available to benefit the wider community of people affected by this "life limiting" neurological, invisible condition.

Barth Syndrome Foundation's vision is a world in which Barth syndrome no longer causes suffering or loss of life. Their mission is saving lives through education, advances in treatment and finding a cure for Barth syndrome.

Beacon for Rare Diseases (formerly Findacure) is a UK charity building the rare disease community to drive research and develop treatments. We work to: empower patient groups to build their patient community, develop as a charity, and drive treatment research and development, and promote collaborations between rare disease stakeholders to facilitate treatment development for all. Beacon follows in the footsteps of William Bateson, the father of modern genetics, who reminded us that we should "treasure our exceptions".

Registered Charity No: 1149646

The Cambridge Rare Disease Network is a newly established charity working to build a regional community of people in Cambridgeshire to address the unmet needs of rare disease patients, their families and the professionals who work with them.

Registered Charity No: 1166365

Our mission is to connect 1M people living with long-term illness, rare disease, or who are still undiagnosed. Our niche is social-emotional support—providing fun and connection for illness warriors worldwide! We believe in the power of connecting people across all diseases, because though our specific challenges may vary, we are ALL on an unexpected health odyssey and there is something special about finding others who “get it” and not having to journey alone!

Registered Charity No: 85-2622373

Childhood Tumour Trust is a charity that supports children, young people and their families affected by Neurofibromatosis type 1, by providing camps for children, days out for families and providing an online support group. They are campaigning to raise awareness and earlier diagnosis.

Registered Charity No: 1165777

CMTUK (aka Charcot Marie Tooth United Kingdom) is the UK charity dedicated to supporting people living with Charcot Marie Tooth Disease.

Courageous Parents Network (CPN) is a nonprofit organization that provides curated digital resources and programming to help caregivers and others caring for children with a serious medical condition to navigate the illness journey with support and a sense of community. CPN resources include video and podcast interviews, educational guides and learning pathways, blogs, and a clinician portal offering materials for use in self-and colleague education. CPN’s programming includes monthly educational webinars and newsletters and both live and virtual presentations to clinician audiences, biotech leaders, and patient organizations.

We’re a registered charity working to raise awareness of cerebrospinal fluid (CSF) leaks, to provide support to sufferers and their families, and to secure diagnostic and treatment advancement.

The Cure & Action for Tay-Sachs (CATS) Foundation is the only charity based in the United Kingdom dedicated to supporting families affected by Tay-Sachs and Sandhoff disease. The CATS Foundation provides vital services to families affected by these devastating diseases, which includes distributing information, providing vital equipment, respite trips, funeral funding and a support network for families and carers. The CATS Foundation are the nominated patient organisation for a ground breaking European gene therapy trial for Tay-Sachs and Sandhoff which is hoped may provide a viable treatment from these diseases.

Registered Charity No: 1144543

Cure CLCN4 is a UK-based research charity aimed at furthering scientific research into CLCN4 condition, a rare genetic disease that causes intellectual disability and other problems such as epilepsy, behavioural disorders, movement disorders and microcephaly. Cure CLCN4’s main objectives are to provide support to CLCN4 affected families, raise awareness, and fund research for effective treatments for CLCN4 condition.

CureDuchenne is recognized as the global leader in research, patient care and innovation for improving and extending the lives of those with Duchenne. We are committed to improving the lives of everyone affected by Duchenne through accelerating research to find the cure, improving care and empowering the Duchenne community.

DEBRA is the national charity and patient support organisation for people living with or directly affected by EB. DEBRA does not receive statutory funding and relies on the income generated by its charity shops and fundraising activities to provide care and support for people living with EB, and to fund pioneering research to find effective treatments and ultimately, cure(s) for EB.

Epilepsy Sparks is the one and only global organisation of its kind: bridging the gap between neuro professionals, patients, scientists, employers, epilepsy charities - and the rest of the world! We empower people through education - providing up to date information about epilepsy and mental health comorbidities; making it interesting and less scary!

EURORDIS-Rare Diseases Europe is a unique, non-profit alliance of 929 rare disease patient organisations from 72 countries that work together to improve the lives of the 30 million people living with a rare disease in Europe. ​

FOP Friends was founded by Chris and Helen, along with close family and friends after their son Oliver was diagnosed with FOP. Over the years, the charity has grown into a nationally and internationally recognised organisation. We support patient and their families who are living with FOP. We fundraise to support the FOP research team at the University of Oxford, led by Professor Alex Bullock. We aim to raise awareness of FOP to help reduce the time to diagnosis and also misdiagnosis. We also organise events to connect people within the community so they don’t feel quite so isolated.

The genetic conditions support network. Supporting individuals and families affected by throughout their diagnosis journey of a genetic condition. Supporting individuals and families affected by genetic conditions. Join us in our mission to enrich the lives of those affected by a genetic condition today by signing up to hear about our fundraising appeals.

Registered Charity No: 1141583

Our Origin: Donna Cryer received a life-saving liver transplant in law school after years of living with an autoimmune disease. On the 20th anniversary of her transplant, she realized her experience as a patient, lawyer, and professional health systems consultant could help fellow patients. In 2014, she founded Global Liver Institute. Our Values: Patient-centeredness. Collaboration. Integrity. Inclusion. Results. Our Mission: To improve the lives of individuals and families impacted by liver disease through promoting innovation, encouraging collaboration, and scaling optimal approaches to help eradicate liver diseases. Our Vision: For liver health awareness to be universal and for liver disease to take its proper place on the global public health agenda consistent with its prevalence and impact.

Registered Charity No: A 501(c)(3) non-profit organization based in Washington, DC

Haemochromatosis UK was founded as The Haemochromatosis Society in 1990, by people affected by genetic haemochromatosis. Our founder, Janet Fernau was recognised for her charitable work in 2011 with a MBE. Our charity is still run by people with genetic haemochromatosis. We work to support anyone affected by the condition, across three key areas : Support Education & Awareness Medical Research The charity works closely with other voluntary sector organisations and is a member of the Genetic Alliance UK. We are 2022 GSK King's Fund IMPACT Award Winners and runner-up Small Charity of the Year in the Third Sector Awards 2022.

Hereditary Brain Aneurysm Support (HBA Support) is a new not-for-profit organisation, set up to provide information and support for people affected by hereditary brain aneurysms and their families. We aim to support people affected by hereditary brain aneurysms, building a community that works with families that have been given a hereditary brain aneurysm diagnosis or suspect there is a pattern or cluster in their family. We will support people affected, improve patient information and increase research and understanding into brain aneurysms that run in families.  Find out more at hbasupport.org

Hope for Hypothalamic Hamartomas-UK (Hope for HH-UK) is a volunteer-run charitable trust registered in the UK, founded by sufferers and parents of children with hypothalamic hamartomas (HH). Our goal is to create a single, credible source for information about the diagnosis, treatment, and support of individuals with HH and to caregivers and healthcare providers. We promote research into early detection, improved treatments, living with HH as a complex medical syndrome, and a cure.

HDYO provides support, education and empowerment to young people and families impacted by Huntington’s Disease.

IFOPA is a non profit organisation. They fund research to find a cure for fibrodysplasia ossificans progressiva (FOP) while supporting, connecting and advocating for individuals with FOP and their families, and raising awareness worldwide.

Lymphangiomatosis and Gorham Disease Alliance (LGDA)

Matthews Friends are a UK registered charity (since 2004) specialising exclusively in medical Ketogenic Dietary Therapies. We support patients, families and professionals by providing information, training, research and grants to develop Ketogenic services and support systems for drug resistant (refractory) epilepsy as well as other neurological and metabolic disorders and emerging cancer types. Our charity is supported by key medical experts so as to ensure the safety and efficacy of our information.

Registered Charity No: 1108016

This medics4rarediseases group aims to bring medical students and medics into contact with both patients and clinicians in order to educate on rare diseases. By educating future doctors we can increase early recognition and diagnosis of rare diseases. Identifying and understanding the biological cause of extreme inherited conditions is helping in the research of treatment for common diseases too – a process known as “translational medicine”.

Registered Charity No: 1166365

The MEF2C Foundation is a UK based charity driving global therapeutic research and development to improve the quality of life for those with MEF2C Haploinsufficiency Syndrome. In parallel we are taking steps to increase awareness of MEF2C Haploinsufficiency and to provide information and support to families of those impacted.

Metabolic Support UK are the leading international organisation for Inherited Metabolic Disorders (IMDs), supporting thousands of patients worldwide through providing individual support, building patient communities, and continually advocating for and empowering those living with IMDs.

Myhre Syndrome is a rare genetic disease first described by Dr. Selma A. Myhre, an American pediatrician, in 1981. In the United States, a rare disease is defined as a condition that affects fewer than 200,000 people. Myhre Syndrome Foundation is dedicated to serving Myhre Syndrome families by providing a network of hope and support and collaborating with scientific and medical communities to encourage and fund promising research. Our goals are simple: - To educate the public and the medical community to ensure early diagnosis and proper treatment. - To promote safe and effective treatments through advocacy, research funding and a comprehensive patient registry. - To provide a caring and supporting community for Myhre patients and families.

The Myrovlytis Trust was founded in 2007 to promote research into rare diseases, and advance education of the public in medical and molecular genetics. With an initial focus on the rare genetic condition Birt-Hogg-Dubé Syndrome and the rare cancer osteosarcoma, our mission is to drive research, provide support and improve outcomes for rare disease patients and their families.

The NCBRS Worldwide Foundation is a nonprofit organisation that aims to support and educate families, carers and professionals who work with people diagnosed with NCBRS. Together we will work to promote awareness and understanding of the syndrome. We advocate for scientific research that increases the medical knowledge of NCBRS and best treatments. Our vision is to create a global community where families, healthcare professionals and researchers work together to ensure that every person diagnosed with Nicolaides-Baraitser Syndrome has every opportunity to reach their full potential.

Neuroacanthocytosis (NA) is a group of ultra-rare, debilitating and progressive diseases that affect the basal ganglia part of the brain, often characterized by the presence of high levels of 'spikey'-red blood cells (acanthocytosis). As a result of cell death, many difficulties including involuntary muscle spasms causing abnormal movement and balance, slowness in thought and action and seizures may occur that impact daily life. NA Advocacy was formed to assist patients and families, promote international collaboration, fund research and establish a virtual database. Furthermore, the charity has supported nine global symposiums that bring together clinicians, researchers, families and patients in an effort to further treatments to alleviate the effects of NA and ultimately to find a cure.

Registered Charity No: 1133182

Niemann-Pick UK (NPUK) is a charitable organisation dedicated to making a positive difference to the lives of those affected by Niemann-Pick diseases. We raise much needed awareness, provide practical and emotional support, advice and information and facilitate research into potential therapies.

The PBC Foundation is the only UK organisation exclusively dedicated to providing support and information to those affected by Primary Biliary Cholangitis, an autoimmune liver condition with no known cause or cure. Our aims and objectives are to provide PBC sufferers with accurate, up-to-date information on PBC and support, while educating medical practitioners and driving research

Registered Charity No: SC207493

Pitt Hopkins UK are a newly registered charity. Their aims are to raise awareness of Pitt-Hopkins Syndrome (PTHS), particularly among the health professionals, and to support and advocate for families with a child with PTHS, while delivering the latest information. Pitt Hopkins UK also hope to fund future research in key areas which impact quality of life, such as - the breathing anomalies that many of the children and adults exhibit.

Registered Charity No: 1167153

PRISMS (Parents and Researchers Interested in Smith-Magenis Syndrome) is an advocacy, education, and support organization for individuals with Smith-Magenis Syndrome (SMS), their families, and the professionals who serve them. PRISMS is a nonprofit 501(c)(3) organization formed on February 4, 1993 by a group of parents and professionals with a desire to build education, awareness, and research opportunities for all those affected by SMS.

PSPA is the only UK charity dedicated to creating a better future for people living with PSP & CBD. We do this by providing support and information to people living with PSP & CBD, while funding research into treatments and ultimately a cure. We rely entirely on voluntary donations.

Raregivers™ is a global network that delivers emotional support to caregivers, patients and professionals in rare, chronic and complex disease communities. We deliver daily compassion and relief to individuals who feel isolated and overwhelmed. Our organization is singularly focused on providing necessary mental health and wellness services to raregivers – from sustainable psychosocial training and transformative retreats to a connective peer-to-peer multilingual network. Raregivers currently supports over 20,000 rare families across 33 countries, with a goal to connect and educate 3.5 million Raregivers™ by 2026.

Rett UK is a national charity dedicated to supporting and empowering people with Rett syndrome and their families. They provide professional family-support services at local, regional and national level; educate health and social care professionals; advocate for people with Rett Syndrome and promote, support and encourage research into new therapies and treatments.

Ring20 Research and Support UK are a non-profit making charitable organisation operating from the UK but who extend their support to families around the world affected by Ring Chromosomes 20 Syndrome. Ring20 raise funds for future research studies by way of member fundraising and seeking out opportunities for research grants and/or corporate sponsorship. They aim to represent r(20) patients and their families as a patient cohort to aid vital research, which may lead to improved quality of life and improved outcomes for those living with, or affected by r(20).

Registered Charity No: 1165651

A new charity (2019) for those with rare salivary gland cancers such as adenoid cystic carcinoma (ACC). The charity aims to build a UK-wide information and support network for people affected by these conditions. Giving opportunities to input into ground-breaking research projects and working to develop and improve access to the newest therapies. They are focused on patients and clinicians working together to drive research and increase knowledge.

Registered Charity No: 1182762

The Schinzel-Giedion Syndrome Foundation is a registered UK charity established in 2019 by an international group of parents of children with Schinzel-Giedion Syndrome (SGS). Our foundation has been created to represent children with SGS and their families living all around the world. Our mission is to provide support to families caring for a child with SGS, to raise awareness of SGS and to facilitate and support medical research that will help us find better treatments to improve the quality and length of life of children living with SGS. Our vision is for a future when all children with SGS will receive a rapid genetic diagnosis and have access to effective medical and gene therapies to ensure they live longer, healthier and happier lives.

Registered Charity No: 1186327

Teach RARE’s mission is to provide educational activities and support for families of rare diseases, undiagnosed diseases, and special needs. In addition, we create awareness about rare diseases and seek to improve early diagnosis and treatment opportunities.

​We raise awareness of Twin Anemia Polycythemia Sequence and raise funds for research into twin complications. Our mission is to get equal, standardized care worldwide and make TAPS education a priority. We’re on top of the latest research and work together with researchers to break down the barriers of jargon so patients can successfully advocate for the standard of care they deserve.

The Ehlers-Danlos Society is a global organisation dedicated to advancing and accelerating research and education in Ehlers-Danlos syndromes (EDS) and hypermobility spectrum disorders (HSD). We support the development of effective and equitable EDS and HSD therapies and work collaboratively to improve the lives of individuals affected by EDS and HSD.

The Gauchers Association is a registered charity that seeks to provide information about Gaucher disease and keep families and medical advisers up to date with latest research developments. They aim to encourage the availability of treatment including enzyme replacement therapy, keep families in touch for support and actively promote medical research into Gaucher disease.

Registered Charity No: 1095657

The Muscle Help Foundation is a small, niche, multi-award-winning family charity delivering transformational experiences in the UK called ‘Muscle Dreams’ for children and young people (aged 8-28 yrs) with the muscle wasting disease, Muscular Dystrophy (MD) and allied neuromuscular conditions. Find out more about their work, impact, their #powerof657 campaign and the difference you can make in helping them change lives and give hope.

Registered Charity No: 1096716

We work closely with patient groups and foundations, pharma and biotech, and the academic community. We bring a unique set of programs to the table, enabling us to add value at any stage - from building the initial knowledge base to enabling therapeutic development. Through our grants, Programs of Excellence, JumpStart programs, and a number of new initiatives, the ODC seeks to drive therapeutic development for rare diseases. We help identify and fund the most promising therapeutics while also tackling obstacles present in rare disease drug development.

​Timothy Syndrome Alliance is a global community dedicated to improving the lives of those affected by a rare, genetic multisystem disorder caused by changes to a gene called CACNA1C which results in significant health concerns (cardiac, neurological, endocrinological and gastrointestinal). There are currently no treatment options. Our mission is to improve the diagnosis, treatment and care of CACNA1C-related disorders and to support the families of those diagnosed.

Registered Charity No: 1185523

Usher Syndrome Ireland is a voluntary charity set up support, advocate, and fund global research to find a cure for this rare genetic disease with its main symptoms causing both hearing loss and progressive sight loss leading to deafblindness. Usher syndrome is the leading genetic cause for deafblindness for which there is no cure nor treatment.

wAIHA Warriors exists to improve the quality of life for all people affected by warm Autoimmune Hemolytic Anemia through programs of research, education, support, and advocacy.

Wolfram Syndrome UK (WSUK) are the only charity and website in the UK for this ultra-rare condition. WS has four main features - Diabetes Insipidus, Diabetes Mellitus, Optic Atrophy and Deafness. The two features that should alert a medical professional to the possibility of WS are the Type 1 diabetes and vision loss or OA. No two patients are affected the same and there are many additional medical issues that an affected person can develop. As many medical professionals have never heard or come across the syndrome, it was felt the UK required a website where these professionals and families could find information and support that might be helpful to them. WSUK as a national charity help fund research and provide support for those affected by the condition and their families. We feel the more people that know about WS the better; and will endeavour to make sure that hospitals, doctors and other health care professionals are aware of this site.

Registered Charity No: 1152445

The YWHAG Research Foundation seeks to raise awareness and educate the public on the YWHAG genetic mutation, while supporting the families affected by this mutation. We strive to advance research and understanding on this rare and understudied disease.